Announcement

Collapse
No announcement yet.

WHO & Other Major Medical Stakeholders Push Back On Suggested Acetaminophen/Autism Link - LANCET Meta-Analysis January 2026

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • WHO & Other Major Medical Stakeholders Push Back On Suggested Acetaminophen/Autism Link - LANCET Meta-Analysis January 2026

    WHO & Other Major Medical Stakeholders Push Back On Suggested Acetaminophen/Autism Link


    Photo Credit – Wikipedia

    #18,883

    This week's announcement by the White House linking the use of acetaminophen (Tylenol/Paracetamol) by pregnant women to a rise in autism is problematic because these OTC pain/fever relievers are considered the safest option for both the mother and unborn child.

    We've previously looked at potential drivers of increased autism, and after genetics, environmental exposures, and increased recognition of those on the spectrum, fevers during pregnancy are frequently cited (see Molecular Psy.: Increased Autism Risk Linked To Prenatal Fever).


    Taking away the only `presumed safe' option to reduce fevers could actually end up increasing the incidence of autism, instead of decreasing it. So too, could ACIP's recent move away from strongly recommending the COVID vaccine for pregnant women.

    While a few studies have claimed a statistical link between acetaminophen use during pregnancy and autism (Link), none have found a causal link, and one of the most robust recent (2024) studies (see Acetaminophen Use During Pregnancy and Children’s Risk of Autism, ADHD, and Intellectual Disability) found:

    Conclusions and Relevance Acetaminophen use during pregnancy was not associated with children’s risk of autism, ADHD, or intellectual disability in sibling control analysis. This suggests that associations observed in other models may have been attributable to familial confounding.


    Even the FDA - as of 2 days ago - finds no causal link has been established, writing:

    It is important to note that while an association between acetaminophen and neurological conditions has been described in many studies, a causal relationship has not been established and there are contrary studies in the scientific literature.
    It is also noted that acetaminophen is the only over-the-counter drug approved for use to treat fevers during pregnancy, and high fevers in pregnant women can pose a risk to their children. Additionally, aspirin and ibuprofen have well-documented adverse impacts on the fetus.


    The American Academy of Pediatrics (AAP) released a statement on the White House Autism Announcement calling it `dangerous' and `misleading', as have others (see here & here).

    Overnight the WHO weighed in, with the following statement:

    WHO statement on autism-related issues
    24 September 2025

    The World Health Organization (WHO) emphasizes that there is currently no conclusive scientific evidence confirming a possible link between autism and use of acetaminophen (also known as paracetamol) during pregnancy.

    Globally, nearly 62 million people (1 in 127) have autism spectrum disorder, a diverse group of conditions related to development of the brain. Although awareness and diagnosis have improved in recent years, the exact causes of autism have not been established, and it is understood there are multiple factors that can be involved.

    Extensive research has been undertaken over the past decade, including large-scale studies, looking into links between acetaminophen use during pregnancy and autism. At this time, no consistent association has been established.

    WHO recommends that all women continue to follow advice of their doctors or health workers, who can help assess individual circumstances and recommend necessary medicines. Any medicine should be used with caution during pregnancy, especially in the first three months, and in line with advice from health professionals.

    Also, a robust, extensive evidence base exists showing childhood vaccines do not cause autism. Large, high-quality  studies from many countries have all reached the same conclusion. Original studies suggesting a link were flawed and have been discredited. Since 1999, independent experts advising WHO have repeatedly confirmed that vaccines—including those with thiomersal or aluminum—do not cause autism or other developmental disorders.  

    Childhood vaccine schedules are developed through a careful, extensive and evidence-based process involving global experts and country input. The childhood immunization schedule, carefully guided by WHO, has been adopted by all countries, and has saved at least 154 million lives over the past 50 years. The schedule remains essential for the health and wellbeing of every child and every community. These schedules have continually evolved with science and now safeguard children, adolescents and adults against 30 infectious diseases.

    Every vaccine recommendation by the Strategic Advisory Group of Experts on Immunization (SAGE), an independent advisory group to WHO, is grounded in rigorous review of evidence and carefully designed to offer the best protection against serious diseases and to be delivered when most needed.

    When immunization schedules are delayed or disrupted, or altered without evidence review, there is a sharp increase in the risk of infection not only for the child, but also for the wider community. Infants too young to be vaccinated and people with weakened immune systems or underlying health conditions are at greatest risk.

    Autism and neurodevelopmental disorders are among priority mental health and neurological conditions being discussed at the 4th UN High-Level Meeting on NCDs and mental health this Thursday, 25 September. As a global community, we need to do more to understand the causes of autism and how best to care for and support the needs of autistic people and their families.  

    WHO is committed to advancing this goal working together with partners including autistic-led organizations and other organizations representing persons with lived experience. WHO also stands with people who are living with autism and their families, a dignified community entitled to evidence-based considerations free of stigma.


    With any medication there is always a risk-reward calculation involved: Is the risk (no matter how slight) worth the benefit from taking the medication.
    There is, after all, no such thing as a 100% benign drug or vaccine (for 100% of the population). And anything - even life sustaining water and oxygen - can be toxic (or even fatal) if ingested in too high a dose.


    We've also looked at the dangers of of acetaminophen in high doses (see A Reminder To Know Your Dose). But, as the father of toxicology - Paracelsus (1493-1541) - famously stated : `The dose makes the poison".

    For now, the mainstream medical community stands behind the rational use of acetaminophen during pregnancy, as the evidence of harm is insufficient.


    While it is possible that additional evidence could change that stance, the risks of not treating a high fevers during pregnancy are well established, and is almost certainly the greater risk.


    Photo Credit – Wikipedia #18,883 This week's  announcement by the White House  linking the use of acetaminophen (Tylenol/Paracetamol) by pre...
    Last edited by Michael Coston; January 19, 2026, 07:45 AM.
    All medical discussions are for educational purposes. I am not a doctor, just a retired paramedic. Nothing I post should be construed as specific medical advice. If you have a medical problem, see your physician.

  • #2
    The Lancet: Prenatal Paracetamol Exposure and Child Neurodevelopment: A Systematic Review and Meta-Analysis


    Photo Credit – Wikipedia


    #19,023

    Last September the WHO & Other Major Medical Stakeholders Pushed Back On A Suggested Acetaminophen/Autism Link after the White House issued an announcement suggesting that such a link existed.

    Acetaminophen/Paracetamol have long been considered the safest analgesic & antipyretic drugs for pregnant women and their unborn child, with few safe alternatives currently available.

    While a few studies have claimed a statistical link between acetaminophen use during pregnancy and autism (Link), none have found a causal link, and one of the most robust recent (2024) studies (see Acetaminophen Use During Pregnancy and Children’s Risk of Autism, ADHD, and Intellectual Disability) found:

    Conclusions and Relevance Acetaminophen use during pregnancy was not associated with children’s risk of autism, ADHD, or intellectual disability in sibling control analysis. This suggests that associations observed in other models may have been attributable to familial confounding.

    We've previously looked at potential drivers of increased autism, and after genetics, environmental exposures, and increased recognition of those on the spectrum, fevers during pregnancy are frequently cited (see Molecular Psy.: Increased Autism Risk Linked To Prenatal Fever).

    The concern is that discouraging the use of the only `presumed safe' option to reduce fevers could actually end up increasing the incidence of autism, instead of decreasing it.

    Admittedly, no medication is 100% safe for 100% of the population 100% of the time. As with everything in life, there there is always a risk-reward calculation involved: Is the risk (no matter how slight) worth the benefit?

    While absolute statements on the absolute safety of any drug are impossible to make, over the weekend The Lancet has published a Systematic Review and Meta Analysis on Paracetamol/Acetaminophen exposure and child neurodevelopment.

    This review incorporated 43 studies (17 of which were combined in the meta-analysis), and they report:

    Current evidence does not indicate a clinically important increase in the likelihood of autism spectrum disorder, ADHD, or intellectual disability in children of pregnant individuals who use paracetamol as directed, supporting existing recommendations on its safety.

    While additional research is still needed to better understand heavy or prolonged usage, these findings should be reassuring to anyone who chooses to use these drugs during pregnancy.

    Under Implications of all the available evidence, the authors write:

    Taken together with large-scale sibling-controlled studies from Sweden and Japan published in 2024 and 2025, our findings support the safety of paracetamol when used appropriately during pregnancy. They reinforce the guidance of major professional and regulatory bodies, including the American College of Obstetricians and Gynecologists, the Royal College of Obstetricians and Gynaecologists, and the European Medicines Agency, which continue to recommend paracetamol as the first-line analgesic and antipyretic in pregnancy.

    Avoiding paracetamol based on inconclusive or biased evidence might increase the risk of maternal fever or untreated pain, both of which can harm pregnancy outcomes. Future research should focus on improving exposure measurement, standardising outcome definitions, and integrating mechanistic and family-based designs to clarify any residual uncertainties.

    I've posted the link and the abstract from the open-access meta-analysis below.

    Prenatal paracetamol exposure and child neurodevelopment: a systematic review and meta-analysis
    Francesco D'Antonio, PhDa,† ∙ Maria Elena Flacco, PhDb,† ∙ Lorenza Della Valle, MBBSc ∙ Smriti Prasad, MRCOGd ∙ Lamberto Manzoli, PhDf ∙ Athina Samara, PhDg,h,i ∙ et al.

    Download PDF

    Summary

    Background

    Concerns have emerged about the impact of paracetamol use in pregnancy on child neurodevelopment, particularly in relation to autism spectrum disorder. We aimed to synthesise available evidence to investigate associations between prenatal paracetamol exposure and autism spectrum disorder, attention-deficit hyperactivity disorder (ADHD), and intellectual disability.

    Methods

    For this systematic review and meta-analysis, we searched MEDLINE, Embase,
    ClinicalTrials.gov, and the Cochrane Library from inception to Sept 30, 2025, for cohort studies reporting adjusted estimates of the risk of autism spectrum disorder, ADHD, and intellectual disability. Eligible studies used validated questionnaires or medical records to define outcomes, reported maternal comorbidities and treatments, and compared pregnancies with and without paracetamol exposure, whereas unadjusted studies were excluded. Quality assessment of the included studies was conducted using the Quality In Prognosis Studies (QUIPS) tool. The primary outcomes were the associations between prenatal paracetamol exposure and the likelihood of autism spectrum disorder, ADHD, and intellectual disability. Analyses were restricted to sibling-comparison studies with adjusted estimates, and odds ratios (OR) were calculated. Random-effects meta-analyses used the generic inverse variance method. Subgroup analyses were performed when possible (trimester, duration of use, offspring sex, and follow-up length). This study was registered with PROSPERO, CRD420251156690.

    Findings

    43 studies were included in the systematic review, and 17 studies in the meta-analysis. When considering sibling comparison studies, paracetamol exposure during pregnancy was not associated with the risk of autism spectrum disorder (OR 0·98, 95% CI 0·93–1·03; p=0·45), ADHD (0·95, 0·86–1·05; p=0·31), or intellectual disability (0·93, 0·69–1·24; p=0·63).

    There was also no association between paracetamol intake during pregnancy and autism spectrum disorder (OR 1·03, 95% CI 0·86–1·23; p=0·78), ADHD (0·97, 0·89–1·05; p=0·49), or intellectual disability (1·11, 0·92–1·34; p=0·28) when considering only studies at low risk of bias according to QUIPS. This absence of association persisted when considering all studies with adjusted estimates and those with more than 5 years of follow-up.

    Interpretation
    Current evidence does not indicate a clinically important increase in the likelihood of autism spectrum disorder, ADHD, or intellectual disability in children of pregnant individuals who use paracetamol as directed, supporting existing recommendations on its safety.




    Photo Credit – Wikipedia #19,023 Last September the  WHO & Other Major Medical Stakeholders Pushed Back On A Suggested Acetaminophen/Autism ...

    All medical discussions are for educational purposes. I am not a doctor, just a retired paramedic. Nothing I post should be construed as specific medical advice. If you have a medical problem, see your physician.

    Comment


    • #3
      CMAJ: Acetaminophen in pregnancy


      Photo Credit – Wikipedia

      #19,186

      Last September, following a White House announcement suggesting a link between acetaminophen use during pregnancy and rising rates of autism, we looked at a statement from the World Health Organization and other medical stakeholders which pushed back on the theory.

      While no drug can claim to be 100% safe in 100% of the people that take it, these OTC pain/fever relievers have long been considered the safest option for both the mother and unborn child.

      We've looked at potential drivers of increased autism often over the years, and after genetics, environmental exposures - and increased recognition of those on the spectrum - fevers during pregnancy are frequently cited (see Molecular Psy.: Increased Autism Risk Linked To Prenatal Fever).

      While a few studies have claimed a statistical link between acetaminophen use during pregnancy and autism (Link), none have found a causal link, and a large 2024 study found `Acetaminophen use during pregnancy was not associated with children’s risk of autism, ADHD, or intellectual disability in sibling control analysis.'

      The concern is: disparaging the only `presumed safe' option to reduce maternal fevers could actually end up increasing the incidence of autism, instead of decreasing it.

      We revisited this story last January in The Lancet: Prenatal Paracetamol Exposure and Child Neurodevelopment: A Systematic Review and Meta-Analysis, which incorporated 43 studies (17 of which were combined in the meta-analysis), which reported:

      Current evidence does not indicate a clinically important increase in the likelihood of autism spectrum disorder, ADHD, or intellectual disability in children of pregnant individuals who use paracetamol as directed, supporting existing recommendations on its safety.

      Additional research is still needed to better understand heavy or prolonged usage, but these findings should be reassuring to anyone who chooses to use these drugs during pregnancy.

      Under Implications of all the available evidence, the authors wrote:

      Taken together with large-scale sibling-controlled studies from Sweden and Japan published in 2024 and 2025, our findings support the safety of paracetamol when used appropriately during pregnancy. They reinforce the guidance of major professional and regulatory bodies, including the American College of Obstetricians and Gynecologists, the Royal College of Obstetricians and Gynaecologists, and the European Medicines Agency, which continue to recommend paracetamol as the first-line analgesic and antipyretic in pregnancy.

      Avoiding paracetamol based on inconclusive or biased evidence might increase the risk of maternal fever or untreated pain, both of which can harm pregnancy outcomes. Future research should focus on improving exposure measurement, standardising outcome definitions, and integrating mechanistic and family-based designs to clarify any residual uncertainties.

      Admittedly, not a rock solid 100% guarantee of absolute safety; but in life, precious little is.

      Weighing in on all of this, yesterday the CMAJ published a brief review on the use of acetaminophen in pregnancy, and they too find that `Current evidence does not indicate a causal link between acetaminophen use in pregnancy and adverse infant outcomes.'

      For those looking for a bit more reassurance, I've posted their report below.

      Acetaminophen in pregnancy
      Jonathan S. Zipursky Rachela Smith and Tali Bogler CMAJ
      June 01, 2026
      DOI: https://doi.org/10.1503/cmaj.260138

      PDF

      Acetaminophen is the preferred analgesic and antipyretic agent for pregnant people

      More than half of pregnant people use acetaminophen, most commonly for pain.
      1 Compared with alternatives, acetaminophen is the best studied analgesic and antipyretic in pregnancy and has the most reassuring maternal and fetal safety profiles. Major regulatory and obstetrical organizations support judicious use of acetaminophen as the first-line treatment for fever and pain in pregnancy.2

      Studies on the risks of neurodevelopmental disorders related to acetaminophen use in pregnancy have not established causation

      Some systematic reviews suggest small associations between prenatal acetaminophen use and autism spectrum disorder and attention-deficit/hyperactivity disorder. However, studies that rigorously control for potential confounders or emphasize sibling-controlled designs have typically found weaker or null associations.
      3,4 This suggests that unmeasured confounders (e.g., genetic and environmental factors) largely explain the associations with neurodevelopmental disorders.5 Randomized controlled trials have not been conducted, and therefore methodological weaknesses in existing observational studies limit conclusions about causation.

      Data on fetal reproductive and endocrine effects show small, inconsistent associations

      Results from observational studies linking prenatal acetaminophen use to abnormalities in the male reproductive tract are inconsistent; some studies have demonstrated small associations with cryptorchidism and reduced anogenital distance, while others have not.
      5 Furthermore, most studies relied on maternal memory of acetaminophen use in pregnancy, raising the potential for recall bias that may increase observed effect sizes or lead to spurious associations.

      Untreated maternal fever has been associated with adverse fetal outcomes

      Separating the potential effects of acetaminophen from those of the underlying condition is challenging. Treatment of fever in pregnancy is clinically indicated; in some observational studies, maternal fever was linked to increased risks of neurodevelopmental disorders.
      6 First-trimester fevers have been linked to congenital abnormalities such as neural tube, heart, and oral cleft defects.7

      Counselling on acetaminophen use in pregnancy should emphasize a critical approach to interpreting the data

      Current evidence does not indicate a causal link between acetaminophen use in pregnancy and adverse infant outcomes. Clear counselling by clinicians about the limitations of existing observational data can reduce unnecessary anxiety or avoidance of appropriate fever and pain treatment in pregnancy.


      https://afludiary.blogspot.com/2026/...pregnancy.html
      All medical discussions are for educational purposes. I am not a doctor, just a retired paramedic. Nothing I post should be construed as specific medical advice. If you have a medical problem, see your physician.

      Comment

      Working...
      X